Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
about
Antibiotic resistance in primary care in Austria - a systematic review of scientific and grey literatureThe relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data.Longitudinal surveillance of outpatient quinolone antimicrobial use in Canada.Prostate-specific antigen reduction after empiric antibiotic treatment does not rule out biopsy in patients with lower urinary tract symptoms: prospective, controlled, single-center study.Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study.The appropriateness of prescribing antibiotics in the community in Europe: study design.Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital.Antimicrobial resistance in Neisseria gonorrhoeae in China: a meta-analysisFactors associated with doctors' knowledge on antibiotic use in ChinaConnection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.Association between antimicrobial consumption and resistance in Escherichia coli.Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.Molecular Characterization of Uropathogenic Escherichia coli: Nalidixic Acid and Ciprofloxacin Resistance, Virulent Factors and Phylogenetic BackgroundSocioeconomic factors and antibiotic use in relation to antimicrobial resistance in the Amazonian area of Peru.Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial.Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.Risk factors for coexistence of fluoroquinolone resistance and ESBL production among Enterobacteriaceae in a Greek university hospital.Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.Tetracycline resistant plasmids from uropathogenic Escherichia coli from Southwestern Nigeria.Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.Restoration of antibiotic susceptibility in fluoroquinolone-resistant Escherichia coli by targeting acrB with antisense phosphorothioate oligonucleotide encapsulated in novel anion liposome.A few antibiotics can represent the total hospital antibiotic consumption.
P2860
Q26996633-7708C22C-1B45-4662-BC89-253A06C1A9B7Q30991070-DFA35B73-0E10-4F11-9E44-76A895175757Q33640223-77FF5B6F-4A14-4633-8D87-E63EDFF6FBB9Q33739100-73E50B19-5CF6-44F5-9AE9-162A74B78ED1Q34014804-D92F6CEE-DD7E-4037-AA8A-FDA9AA4F9A1EQ34059751-75F83BDF-7CBC-4E3E-B337-BACD10402D80Q34546960-AC5F9124-9EEA-4AD1-82C1-C6B7C1521486Q35945575-BB09B789-8112-41DB-8FF3-36177808F3DBQ36725499-B6EECAB2-4F00-4CE6-9124-F12BA24034DFQ36744739-C0BC0082-6162-4048-A309-CAE20E3F29B5Q37115726-567586B8-0195-42E2-9D89-7FB4EA26292CQ37115781-32E89832-3FA9-47A6-957E-1E78AD031207Q37573324-D1CE06F8-CEBD-4A4A-B85D-E6F16227ECF6Q39875981-4D99B722-F4B3-416B-B548-5900147A7156Q40127044-75239A7C-719F-4DF4-A745-D7B0B2C4A9C7Q41873330-F75954E3-C293-48B6-BF41-E6D54B35D775Q43110171-1DDE0396-D754-4311-8496-812ECEA92074Q44213134-AD06DEF2-7E6A-4090-8AC5-6D9281E21EA2Q46448501-50989275-A88B-4BF4-B9AD-CAB44BAE4BB5Q46713329-50133D6E-B91B-4F44-9768-8D4AE27C2453Q46911661-DAD44B69-10BB-475A-93E8-4E9CEDFD0102Q47706758-0EC3D1F7-3477-4520-9A96-DF0A28F6524EQ54345829-6F69C39D-9B71-49EA-B700-F0E0940E396EQ55014101-17E42E3A-E519-47EC-AE97-5EC536774BE6
P2860
Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Non-hospital antimicrobial usa ...... coli urinary tract infection.
@en
Non-hospital antimicrobial usa ...... coli urinary tract infection.
@nl
type
label
Non-hospital antimicrobial usa ...... coli urinary tract infection.
@en
Non-hospital antimicrobial usa ...... coli urinary tract infection.
@nl
prefLabel
Non-hospital antimicrobial usa ...... coli urinary tract infection.
@en
Non-hospital antimicrobial usa ...... coli urinary tract infection.
@nl
P2093
P356
P1476
Non-hospital antimicrobial usa ...... coli urinary tract infection.
@en
P2093
P304
P356
10.1093/JAC/DKG488
P407
P577
2003-11-12T00:00:00Z